학술논문

Biomarkers of response to abiraterone and the polo-like kinase 1 (PLK1) inhibitor onvansertib in metastatic castration resistant prostate cancer (mCRPC) patients
Document Type
Journal
Source
CANCER RESEARCH; JUN 15 2022, 82 12, 1p. Supplement: S
Subject
Language
English
ISSN
15387445